April 19 (UPI) -- Former pharmaceutical executive Martin Shkreli will be tried separately from his former attorney on securities fraud charges, a federal judge in New York City decided Wednesday.
Shkreli, 34, the former chief executive of Turing Pharmaceuticals, had requested a separate trial from co-defendant Evan Greebel in the case. The Brooklyn District Court judge on Wednesday said trying the pair at the same time could jeopardize Shkreli's right to a fair trial.